AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 221 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 12.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,126,893 | -18.7% | 24,503 | +1.6% | 0.01% | -35.3% |
| Q2 2023 | $1,385,429 | +230804.8% | 24,107 | +50.6% | 0.02% | +88.9% |
| Q1 2023 | $600 | -99.9% | 16,010 | -47.8% | 0.01% | -67.9% |
| Q2 2022 | $1,067,000 | -26.4% | 30,676 | -24.1% | 0.03% | -17.6% |
| Q1 2022 | $1,450,000 | +42.4% | 40,395 | -7.6% | 0.03% | +100.0% |
| Q4 2021 | $1,018,000 | +23.2% | 43,712 | +0.6% | 0.02% | +30.8% |
| Q3 2021 | $826,000 | +9.4% | 43,459 | +16.1% | 0.01% | -7.1% |
| Q2 2021 | $755,000 | -5.9% | 37,433 | -14.5% | 0.01% | -12.5% |
| Q1 2021 | $802,000 | +52.8% | 43,789 | +67.6% | 0.02% | +6.7% |
| Q4 2020 | $525,000 | +2.3% | 26,122 | -26.2% | 0.02% | -6.2% |
| Q1 2017 | $513,000 | +5.3% | 35,387 | +33.9% | 0.02% | +23.1% |
| Q4 2016 | $487,000 | -3.9% | 26,427 | -1.2% | 0.01% | +8.3% |
| Q3 2016 | $507,000 | +3.9% | 26,743 | -11.7% | 0.01% | +20.0% |
| Q2 2016 | $488,000 | +99.2% | 30,276 | +48.5% | 0.01% | +66.7% |
| Q1 2016 | $245,000 | – | 20,389 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRIESS ASSOCIATES LLC | 97,760 | $3,401,000 | 5.68% |
| Nantahala Capital Management | 1,000,000 | $34,790,000 | 1.74% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 341,294 | $11,874,000 | 1.52% |
| Portolan Capital Management | 274,889 | $9,563,000 | 0.96% |
| Quantedge Capital Pte Ltd | 121,500 | $4,227,000 | 0.85% |
| SHAKER INVESTMENTS LLC/OH | 37,117 | $1,291,000 | 0.82% |
| GLOBEFLEX CAPITAL L P | 72,253 | $2,514,000 | 0.61% |
| EAM Investors, LLC | 68,855 | $2,395,000 | 0.58% |
| Hillsdale Investment Management Inc. | 197,738 | $6,879,000 | 0.55% |
| Capital Impact Advisors, LLC | 13,835 | $481,000 | 0.44% |